Artesunate attenuates traumatic brain injury-induced impairments in rats
Background: Blood–brain barrier (BBB) dysfunction and neuroinflammation induced by traumatic brain injuries (TBIs) cause a succession of secondary brain damage events and finally lead to a massive and progressive cerebral neuronal destruction. Artesunate, a semisynthetic artemisinin derivative, is a potential candidate for the management of cerebral damage induced by TBI due to its protective function to BBB and cerebral neurons. Methods: To demonstrate the effect of artesunate to TBI-induced BBB dysfunction and neural damage, TBI rat model was constructed by cortical impact injury. Behavioral experiments were used to estimate the impact of the combined treatment on rats. Western blotting was performed to demonstrate the protein levels in the brain tissues of rats. Quantitative real-time PCRs were utilized to investigate the alteration in the expression of various RNA levels. The chemokine levels were estimated by ELISA. Results: Artesunate treatment attenuated the impact caused by TBI on rat brain and improved the long-term neurological recover. Artesunate treatment protected the integrity of BBB and inhibited neuroinflammation. Artesunate treatment promoted the phosphorylation of Akt and inhibited the phosphorylation of glycogen synthase kinase (GSK)-3β in TBI rat model. Conclusion: Artesunate protected rats from TBI-induced impairments of BBB and improved longer-term neurological outcomes.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Artesunate attenuates traumatic brain injury-induced impairments in rats ; volume:11 ; number:1 ; year:2020 ; pages:309-318 ; extent:10
Translational Neuroscience ; 11, Heft 1 (2020), 309-318 (gesamt 10)
- Urheber
-
Zhou, Zhike
Hou, Jun
Li, Qinghua
- DOI
-
10.1515/tnsci-2020-0136
- URN
-
urn:nbn:de:101:1-2022111513145203906553
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:33 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhou, Zhike
- Hou, Jun
- Li, Qinghua
Ähnliche Objekte (12)
Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis
Traumatic brain injury-induced disruption of the circadian clock
Traumatic brain injury-induced cerebral microbleeds in the elderly
Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3
CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies
Myricetin suppresses traumatic brain injury-induced inflammatory response via EGFR/AKT/STAT pathway
Traumatic brain injury-induced submissive behavior in rats: link to depression and anxiety
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Oxytocin attenuates hypothalamic injury-induced cognitive dysfunction by inhibiting hippocampal ERK signaling and Aβ deposition
Omega-3 polyunsaturated fatty acid attenuates traumatic brain injury-induced neuronal apoptosis by inducing autophagy through the upregulation of SIRT1-mediated deacetylation of Beclin-1
Repeated closed-head mild traumatic brain injury-induced inflammation is associated with nociceptive sensitization
Mitochondria Targeted Peptide Attenuates Mitochondrial Dysfunction, Controls Inflammation and Protects Against Spinal Cord Injury-Induced Lung Injury
Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis
Traumatic brain injury-induced disruption of the circadian clock
Traumatic brain injury-induced cerebral microbleeds in the elderly
Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3
CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies
Myricetin suppresses traumatic brain injury-induced inflammatory response via EGFR/AKT/STAT pathway
Traumatic brain injury-induced submissive behavior in rats: link to depression and anxiety
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Oxytocin attenuates hypothalamic injury-induced cognitive dysfunction by inhibiting hippocampal ERK signaling and Aβ deposition
Omega-3 polyunsaturated fatty acid attenuates traumatic brain injury-induced neuronal apoptosis by inducing autophagy through the upregulation of SIRT1-mediated deacetylation of Beclin-1
Repeated closed-head mild traumatic brain injury-induced inflammation is associated with nociceptive sensitization
Mitochondria Targeted Peptide Attenuates Mitochondrial Dysfunction, Controls Inflammation and Protects Against Spinal Cord Injury-Induced Lung Injury
Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis
Traumatic brain injury-induced disruption of the circadian clock
Traumatic brain injury-induced cerebral microbleeds in the elderly
Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3
CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies
Myricetin suppresses traumatic brain injury-induced inflammatory response via EGFR/AKT/STAT pathway
Traumatic brain injury-induced submissive behavior in rats: link to depression and anxiety
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Oxytocin attenuates hypothalamic injury-induced cognitive dysfunction by inhibiting hippocampal ERK signaling and Aβ deposition
Omega-3 polyunsaturated fatty acid attenuates traumatic brain injury-induced neuronal apoptosis by inducing autophagy through the upregulation of SIRT1-mediated deacetylation of Beclin-1
Repeated closed-head mild traumatic brain injury-induced inflammation is associated with nociceptive sensitization